Abstract: Methods for treating lipid storage diseases using compounds that inhibit glucosyltransferase enzymes are disclosed herein. The invention relates to the treatment of lipid storage disease with compounds that inhibit glucosyltransferase activity in the affected cells. It relates particularly to the use of 1,5-dideoxy-1,5-imino-D-glucitol and derivatives thereof.
Type:
Grant
Filed:
April 21, 2000
Date of Patent:
October 15, 2002
Assignee:
Chancellor, Masters & Scholars of the University of
Oxford
Inventors:
Terry D. Butters, Frances M. Platt, Raymond A. Dwek
Abstract: The structure and specificity of the recombinant .alpha.-2,3-sialyltransferases from Neisseria spp, are disclosed. Their use in the production of desired carbohydrate structures is also provided.
Type:
Grant
Filed:
June 7, 1997
Date of Patent:
August 1, 2000
Assignees:
National Research Council of Canada, The Chancellor, Masters and Scholars of the University of Oxford
Inventors:
Michel Gilbert, Warren W. Wakarchuk, Martin N. Young, Michael P. Jennings
Abstract: Tumor rejection antigens derived from tumor rejection precursor MAGE-3 have been identified. These "TRAS" bind to the MHC-class I molecule HLA-A2, and the resulting complexes stimulate the production of cytolytic T cell clones which lyse the presenting cells. The peptides and complexes may be used diagnostically, therapeutically, and as immunogens for the production of antibodies, or as targets for the generation of cytolytic T cell clones.
Type:
Grant
Filed:
June 17, 1994
Date of Patent:
January 7, 1997
Assignees:
Ludwig Institute for Cancer Research, The Chancellor, Masters and Scholars of the University of Oxford
Inventors:
Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre van der Bruggen, Pierre Coulie, Thomas Gajewski
Abstract: Tumor rejection antigens derived from tumor rejection precursor MAGE-3 have been identified. These "TRAS" bind to the MHC-class I molecule HLA-A2, and the resulting complexes stimulate the production of cytolytic T cell clones which lyse the presenting cells. The peptides and complexes may be used diagnostically, therapeutically, and as immunogens for the production of antibodies, or as targets for the generation of cytolytic T cell clones.
Type:
Grant
Filed:
March 24, 1994
Date of Patent:
December 17, 1996
Assignees:
Ludwig Institute for Cancer Research, The Chancellor, Masters and Scholars of the University of Oxford
Inventors:
Alan Townsend, Judy Bastin, Thierry Boon-Falleur, Pierre van der Bruggen, Pierre Coulie
Abstract: A programmable logic device is disclosed which can be used either as a look-up table logic device or as a logic function generator. This enables combinations to be provided such as the combination of a look-up table with a fixed gate field programmable gate array.
Type:
Grant
Filed:
February 3, 1994
Date of Patent:
April 18, 1995
Assignees:
Inmos Limited, Chancellor, Masters and Scholars of the University of Oxford
Abstract: Electrophoresis method and apparatus for separating particles in a separan medium (15) in which provided for driving the particles alternatively in different directions in the separation medium (15). The separation medium (15) is rotated at predetermined intervals in a plane between different rotary positions in one and the same electric field.
Type:
Grant
Filed:
May 28, 1987
Date of Patent:
December 12, 1989
Assignee:
The Chancellor, Masters and Scholars of the University of Oxford